Home  Investors Directors' shareholdings
|
|
The table below shows the interests at 31 December 2007 or on the date of resignation (if earlier) of the persons who on that date were Directors (including the interests of their Connected Persons, as such term is defined in the Companies Act 2006) in shares and debentures of AstraZeneca PLC. All such interests were beneficial except as otherwise stated. None of the Directors has a beneficial interest in the shares of any of the Company’s subsidiaries. Between 31 December 2007 and 31 January 2008 there was no change in the interests in shares and debentures shown in the table below, with the exception of John Patterson who acquired a further 625 Ordinary Shares following the exercise of an option under the AstraZeneca Savings Related Share Option Plan. | | Director | Beneficial interest in Ordinary Shares at 1 Jan 2007 or appointment date | Change to
beneficial interest | Beneficial interest in Ordinary Shares at 31 Dec 2007 or resignation date |
|---|
| Louis Schweitzer | 4,000 | – | 4,000 | | David Brennan | 111,788 | 3,856 | 115,644 | | John Patterson | 8,015 | – | 8,015 | | Simon Lowth1 | – | 850 | 850 | | John Buchanan | 2,500 | – | 2,500 | | Jane Henney | 500 | – | 500 | | Michele Hooper | 500 | – | 500 | | Håkan Mogren | 62,164 | – | 62,164 | | Nancy Rothwell | 500 | – | 500 | | John Varley | 500 | – | 500 | | Marcus Wallenberg | 67,264 | – | 67,264 | | Bo Angelin2 | – | 500 | 500 | | Former Directors | | Jonathan Symonds3 | 11,527 | – | 11,527 | | Peter Bonfield4 | 500 | – | 500 | | Joe Jimenez5 | 500 | – | 500 | | Erna Möller4 | 2,718 | – | 2,718 |
|
|
|
|